Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© putilov_denis - © putilov_denis - stock.adobe.com

Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research

ByKara Bastarache, CAE; Ruma Bhagat, MD, MPH; Beth Bieze, MA, CCRA, ACRP-PM, FACRP; Kimberly Demirhan, MBA, BSN, RN; Mona Gilliam, MSN, APRN-BC, CNS; Susan P. Landis, BA; Katie Marceau, RN, MS-NL, OCN, CCRP; Nicole Richie, PhD; Latha Shivakumar, PhD; and Marian Valia

December 12th 2025

ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis

ByAndy Studna, Senior Editor

December 12th 2025

Integrating Trials into Routine Care

ByGaurav Agrawal,Andy Studna, Senior Editor

December 12th 2025

© photon_photo - © photon_photo - stock.adobe.com

When AI Learns to Speak Every Language: An eCOA Migration Study

ByJonathan Norman

December 11th 2025

ACT Brief: AI’s Impact on Trial Timelines, New Strategies in Obesity R&D, and Why Patient Support Needs a Clinical Backbone

ByAndy Studna, Senior Editor

December 11th 2025

From the Publisher

Articles in this issue

Newsletter

Related Content

Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research

ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis

Integrating Trials into Routine Care

When AI Learns to Speak Every Language: An eCOA Migration Study

ACT Brief: AI’s Impact on Trial Timelines, New Strategies in Obesity R&D, and Why Patient Support Needs a Clinical Backbone

Trending on Applied Clinical Trials Online

When AI Learns to Speak Every Language: An eCOA Migration Study

Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research

ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis

FDA Outlines New Superiority Standard for Future CAR-T Approvals

Integrating Trials into Routine Care